Podcasts about Phase

This week, we're unpacking all the major Peloton news you need to know. First up, Peloton laid out its strategic roadmap at the Citi conference, and we're breaking down what it means for your fitness journey. Plus, get ready for some big schedule changes coming this fall. We're also diving into gem stones appearing on profiles, new Run Club events, and an accidental survey that gave us a sneak peek at what might be next.Peloton reveals its strategic roadmap at the recent Citi conference. We discuss the future of the company and its impact on your fitness.Major schedule changes are coming to Peloton this Fall. What does this mean for your favorite classes and instructors?Have you seen gemstones on some member profiles? We dig into what this new feature is all about.Peloton Studios New York & London are hosting special September Run Club Events.Peloton accidentally sent out a survey with some intriguing questions. We speculate on what could be in the works.A shakeout run has been added for the Peloton community in Berlin.Congratulations to Matt Wilpers and his wife on the birth of their baby!More baby news! Cliff Dwenger and his wife welcomed their second child.It's hard to keep track of all the Peloton instructor babies. We have a complete rundown for you.Becs Gentry's daughter is already a winner, finishing her first race.The New York Times features Peloton instructor Aditi Shah.The latest Artist Series is here, with Phase 2 of the Bad Bunny collaboration.The Armada Music residency has been extended, bringing more electronic dance music to your workouts.Wearable fitness tracker Whoop has a new competitor on the market.TCO Top Five: We recap the top fitness classes of the week as voted by The Clip Out listeners.This Week at Peloton: A look at everything happening in the world of Peloton this week.TCO Radar: We spotlight the upcoming Peloton classes we are most excited about.Chelsea Jackson Roberts & Alex Toussaint are teaming up for a Club Bangers Yoga class.A new series is available for the Yoga + Pilates collection.Peloton Birthdays: We celebrate Anna Greenberg's birthday on September 18th.Enjoying the show? Subscribe to our podcast and leave us a review on Apple Podcasts or Spotify! Your feedback helps us bring you the best Peloton news and fitness insights every week. Visit our website at TheClipOut.com for more. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Interview with Joseph Ovsenek, President & CEO of P2 Gold Inc.Our previous interview: https://www.cruxinvestor.com/posts/p2-gold-inc-tsxvpgld-35moz-project-advances-on-metallurgical-breakthrough-7826Recording date: 11th September 2025P2 Gold presents one of the most compelling value propositions in the current gold mining sector, offering investors exposure to a high-quality Nevada development project with exceptional economics and experienced management execution capabilities. The company's Gabbs project demonstrates robust financial metrics that appear significantly disconnected from its current market valuation, creating a substantial opportunity for value recognition and appreciation.The project's preliminary assessment reveals impressive economics with a 62% internal rate of return and $700 million net present value at a 10% discount rate when current metal prices are applied. These figures stand in stark contrast to P2 Gold's market capitalization of just $25 million, suggesting a potential 28-fold upside if the market recognizes the project's intrinsic value. The 3.5 million ounce gold equivalent resource base provides substantial scale, while the Nevada location offers regulatory advantages and established mining infrastructure that reduce development risks.Recent metallurgical breakthroughs represent a significant catalyst for enhanced project economics and accelerated development timelines. Phase 3 metallurgical results demonstrated remarkable improvements, with gold recovery rates increasing from 78% to 85% and copper recovery jumping from 54% to 67%. Perhaps more importantly, extraction kinetics improved dramatically, with 98% of gold now recoverable in 58 days compared to the previous 145-day timeline. This improvement could reduce capital expenditure requirements and project footprint size when advancing to feasibility study.Management credibility provides crucial execution confidence for investors evaluating development-stage mining opportunities. CEO Joseph Ovsenek and Chief Exploration Officer Ken McNaughton previously collaborated at Pretium Resources, successfully advancing the Bruce Jack project from discovery to production in under eight years. Their proven track record demonstrates capability in navigating complex development processes including resource expansion, permitting, financing, and construction management. The team's philosophy of setting aggressive targets and maintaining development momentum has translated into P2 Gold's ambitious 2028 production timeline.The company's strategic approach to development acceleration includes skipping pre-feasibility study and advancing directly to feasibility based on extensive historical data and the project's straightforward heap leach processing characteristics. This decision could compress typical development timelines while leveraging Nevada's established regulatory framework and heap leach infrastructure. The addition of SART plant technology for gold and copper oxide recovery represents the primary technical innovation required, with numerous similar facilities already operating successfully.Near-term catalysts provide multiple opportunities for market recognition and potential re-rating over the next 12 months. Expansion and infill drilling beginning in mid-to-late October should generate results over six months, potentially expanding the resource base and providing additional geological confidence. Key regulatory milestones including water permitting and mining plan of operation filing within four to five months will demonstrate tangible progress toward production.P2 Gold's current financing round targeting C$6 million with potential expansion based on strong investor interest demonstrates improving market sentiment and capital access. The relatively modest funding requirements reflect the project's efficient development pathway and extensive historical database, allowing the company to maintain aggressive advancement while preserving shareholder dilution.At current gold prices exceeding $3,600 per ounce, P2 Gold offers compelling leverage to continued metal price appreciation while providing downside protection through robust project economics and experienced management execution capabilities.Learn more: https://cruxinvestor.comSign up for Crux Investor: https://cruxinvestor.com

Le FC Stream Team débarque sur Youtube ! Chaque vendredi, retrouvez Martin Mosnier et Maxime Dupuis pour évoquer l'actualité du football. Ligue 1, Ligue des champions, championnats étrangers, nos journalistes choisissent trois sujets et en débattent entre eux. Retrouvez désormais nos journalistes sur la page Youtube Eurosport France : https://www.youtube.com/watch?v=Keol-Yd1dDc&t=221sA bientôt ! Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

This episode is for the writer who is writing, has a big chunk of a manuscript even, but isn't sure about when to enlist the help of an editor. I've worked with a lot of writers who have had negative or lackluster experiences with editors before, and my intention in this episode is to empower you to choose the right editor at the right time with the right manuscript. Let's get started.Enroll in The Memoir Method today, (Phase 1 and Phase 2 are available instant access!).Link to free 30-minute callYou can find me on Instagram @charlottejanewrites, Facebook, and YouTube.Join my email list to stay up to date on the podcast and everything else going on in Charlotte Writes.

Microsoft and OpenAI have issued a joint statement to say that they have signed a non-binding memorandum of understanding for the "next phase" of their partnership. The companies are still finalizing the terms of agreement and haven't shared the details of what their future would look like exactly. In other tech news, Grok has once again been caught spreading blatant misinformation on X. In several bizarre exchanges, the chatbot repeatedly claimed that Charlie Kirk was "fine" and that gruesome videos of his assassination were a "meme edit." And, Merriam-Webster and its parent company Encyclopedia Britannica are the latest to take on AI in court. The plaintiffs have sued Perplexity, claiming that AI company's "answer engine" product unlawfully copies their copyrighted materials. Learn more about your ad choices. Visit podcastchoices.com/adchoices

B shares her take on dating during the "in-between phase." That space between raising teenagers and the empty nest of kids at college. PLUS: Thinking about what YOU bring to the table and how men can be even more emotional than women. See omnystudio.com/listener for privacy information.

B shares her take on dating during the "in-between phase." That space between raising teenagers and the empty nest of kids at college. PLUS: Thinking about what YOU bring to the table and how men can be even more emotional than women. See omnystudio.com/listener for privacy information.

⚠️ The Collapse Chronicles – Episode: AI Takeover

Click HERE and Let's Meet! Chat with us to see if Farm Marketing Mastery can break you out of marketing misery. You're growing incredible products and working harder than anyone you know, but here's the hard truth: if you're like most farmers, you haven't paid yourself a dime for your hard work all year. Here's what most farmers don't realize: marketing isn't magic. It's a skill. And there's a proven system that transforms struggling farmers into sold-out success stories. Key discoveries you'll learn: The #1 mistake on diversified farms that keeps farmers broke How to build a marketing calendar that works with your farm's natural rhythms instead of against them The three marketing assets you already have but aren't using effectively Why listening is the most important marketing skill (and 6 specific ways to do it right) The proof: One client went from six months of begging people to buy her Thanksgiving turkeys to selling out in 24 hours flat using this exact three-phase system. Look, you didn't start farming to become a marketing expert. But if you can't sell what you grow, you won't survive. The farmers who thrive aren't necessarily the best growers—they're the ones who learned how to connect their products to their customers' real problems. Stop struggling and start selling. Your farm deserves to be profitable. FREE Master Class: 5 costly mistakes that are keeping your farm broke Sign Up HERE  

What if a drug could help chemotherapy patients continue treatment without painful side effects? Hoth Therapeutics (NASDAQ: HOTH) is making that possible by developing innovative treatments that address unmet medical needs and help patients maintain their therapy safely.In this interview, CEO Robb Knie discusses HT001, the company's lead drug currently in Phase 2 trials for chemotherapy-induced rash, and HTKIT, which shows promise in cancer treatment. He also shares how the company is advancing programs for Alzheimer's and obesity, including an obesity drug licensed from the U.S. Department of Veterans Affairs.With a diversified pipeline, a patient-focused approach, and strategic use of AI to de-risk and accelerate development, Hoth Therapeutics is positioning itself as a biotech company to watch.Learn more about Hoth Therapeutics: https://hoththerapeutics.comWatch the full YouTube interview here: https://youtu.be/AYQa3g6dVLA?si=w_zDH0TaSxP3m6JiAnd follow us to stay updated: https://www.youtube.com/@GlobalOneMedia?sub_confirmation=1

This week I share with you some insights into a recent check-in with one of my beloved clients. You'll learn how staying consistent and trusting the process has led to some big wins for her and why her body is now ready to begin a strategic fat loss phase.  I pray this episode encourages you!    If this episode helps you, I would love to hear about it! Feel free to DM me on Instagram or leave me a voicemail! The link is below.      Grab my free cheat sheet: Macro Cheat Sheet for Midlife Women   If you enjoyed the episode, please leave me a review or share it with someone who could benefit from it!    Next Steps: If you're ready to ditch the diet and take the next step toward a sustainable path to fitness, book a one-hour coaching call. I would love the opportunity to help you!   During the call you will receive practical, personalized advice and direction to help you to finally know the next step to take in order to make progress with health and fitness in a clear, doable way.   Or need some accountability and community?   Join my free Macros & Midlife, Sustainable Weight Loss for Christian Women Facebook group to chat with other likeminded ladies who are working on improving their health and fitness too!   Follow me on Instagram: Emily Iboa Coaching on Instagram   Do you have a question or a comment you want me to feature on the show? Leave me a voicemail! https://www.speakpipe.com/Macros_Midlife

09-10-25 - Going Through An Authentic Phase John Realizes All The Times His Radar On Things Like Magic Johnson Possibly Being Misdiagnosed Was RightSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

[This is one of the finalists in the 2025 review contest, written by an ACX reader who will remain anonymous until after voting is done. I'll be posting about one of these a week for several months. When you've read them all, I'll ask you to vote for a favorite, so remember which ones you liked] If you've been following this blog for long, you probably know at least a bit about pharmaceutical research. You might know a bit about the sort of subtle measures pharmaceutical companies take to influence doctors' prescribing habits, or how it takes billions of dollars on average to bring a new medication to market, or something about the perverse incentives which determine the FDA's standards for accepting or rejecting a new drug. You might have some idea what kinds of hoops a company has to jump through to conduct actual research which meets legal guidelines for patient safety and autonomy. You may be less familiar though, with how the sausage is actually made. How do pharmaceutical companies actually go through the process of testing a drug on human participants? I'm going to be focusing here on a research subject's view of what are known as Phase I clinical trials, the stage in which prospective drugs are tested for safety and tolerability. This is where researchers aim to answer questions like “Does this drug have any dangerous side effects?” “Through what pathways is it removed from a patient's body?” and “Can we actually give people enough of this drug that it's useful for anything?” This comes before the stage where researchers test how good a drug is at actually treating any sort of disease, when patients who're suffering from the target ailments are given the option receive it as an experimental treatment. In Phase I clinical trials, the participants are healthy volunteers who're participating in research for money. There are almost no cases in which volunteer participation is driven by motivations other than money, because the attitudes between research participants and clinicians overwhelmingly tend to be characterized by mutual guarded distrust. This distrust is baked into the process, both on a cultural level among the participants, and by the clinics' own incentives. All of what follows is drawn from my own experiences, and experiences that other participants in clinical pharmaceutical research have shared with me, because for reasons which should become clear over the course of this review, research which systematically explores the behaviors and motives of clinical research participants is generally not feasible to conduct. https://www.astralcodexten.com/p/your-review-participation-in-phase

09-10-25 - Going Through An Authentic Phase John Realizes All The Times His Radar On Things Like Magic Johnson Possibly Being Misdiagnosed Was RightSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Die Transferphase ist rum, die Länderspielpause ist vorbei und die Bundesliga startet in die heiße Phase! Nik und Felix blicken auf den 3. Spieltag und ihre Top-Kaufempfehlungen. Die Sendung startet mit einer Mannschaftsbesprechung (1:30) und natürlich einer Auseinandersetzung mit dem ersten Trainerwechsel von Bayer Leverkusen - weg von Erik ten Hag und hin zu Kasper Hjulmand. Und natürlich den Kölner Start-Hype. Im Anschluss geht es in die Analyse des 3. Spieltags der Bundesliga. Die Vorschau zu den jeweiligen Partien findet ihr unter folgenden Kapitelmarken: Leverkusen - Frankfurt (8:20) Wolfsburg - Köln (24:35) Freiburg - Stuttgart (31:45) Mainz - Leipzig (43:37) Heidenheim - Dortmund (48:21) Union - Hoffenheim (1:00:04) Bayern - HSV (1:06:52) St. Pauli - Augsburg (1:18:34) Gladbach - Bremen (1:26:05) In der Top-3 der Woche (1:37:10) geht es um die besten Kaufempfehlungen der günstigsten Preisklasse. Und so tippen Felix und Nik den 3. Spieltag: Leverkusen - Frankfurt, Felix: 2:2, Nik: 2:4 Wolfsburg - Köln, Felix: 1:1, Nik: 3:2 Freiburg - Stuttgart, Felix: 1:1, Nik: 0:0 Mainz - Leipzig, Felix: 0:1, Nik: 1:2 Heidenheim - Dortmund, Felix: 0:2, Nik: 1:1 Union - Hoffenheim, Felix: 1:2, Nik: 4:2 Bayern - HSV, Felix: 6:0, Nik: 6:0 St. Pauli - Augsburg, Felix: 2:1, Nik: 2:2 Gladbach - Bremen, Felix: 1:1, Nik: 2:3

In this KE Report company introduction, I speak with Alain Lambert, CEO of Prismo Metals (CSE:PRIZ - OTCQB:PMOMF - FSE:7KU), about the company's expanding project portfolio across Arizona and Mexico. Key Discussion Points: Silver King Mine (Arizona): Historic high-grade silver producer. Surface sampling underway, drill permits pending, and a Phase 1 drill program planned before year-end. Ripsey Mine (Arizona): Another past-producing silver mine with strong gold grades, set for mapping and evaluation as Silver King drilling progresses. Hot Breccia (Arizona Copper Belt): Large copper prospect adjacent to Rio Tinto & BHP's Resolution Copper. A potential partnership with majors is being considered due to deep drilling requirements. Palos Verde (Mexico): Surrounded by Vizsla Silver (NYSE/TSX: VZLA), which is also Prismo's largest shareholder. Potential long-term value once Vizsla advances its exploration in the district. Corporate Overview: Management, directors, and advisors own 26%+, with Vizsla as a cornerstone investor.  .Click here to visit the Prismo Metals website   For more market commentary & interview summaries, subscribe to our Substacks: The KE Report: https://kereport.substack.com/ Shad's resource market commentary: https://excelsiorprosperity.substack.com/   Investment disclaimer: This content is for informational and educational purposes only and does not constitute investment advice, an offer, or a solicitation to buy or sell any security. Investing in equities and commodities involves risk, including the possible loss of principal. Do your own research and consult a licensed financial advisor before making any investment decisions. Guests may own shares in companies mentioned.

Was passiert mit deinem Glauben, wenn Gott plötzlich still wird? Wenn die Antworten, mit denen du aufgewachsen bist, nicht mehr tragen – und stattdessen die Fragen immer lauter werden? Wenn du begreifst, dass du nicht mehr aus Hoffnung, sondern aus Angst glaubst? In dieser Folge erzählt Martin Thoms von genau diesem Moment: seinem ganz persönlichen Schiffbruch. Es ist die Geschichte eines Glaubens, der in sich zusammenfällt – und sich gleichzeitig neu formt. Martin spricht offen über eine tiefe theologische und existenzielle Krise, über das Gefühl, Gott zu verlieren – und die Frage, ob man ihn gerade dann vielleicht zum ersten Mal wirklich begegnet. Was bleibt, wenn nichts mehr sicher ist? Und kann man glauben, ohne alles verstehen zu müssen? Zwischen Hölle, Hoffnung und Allversöhnung Im Zentrum der Krise steht eine Frage, die alles ins Wanken bringt: Warum musste Jesus sterben? Die klassische Kreuzestheologie bietet Martin irgendwann keine Antworten mehr – nur noch Widersprüche. Stattdessen wächst in ihm eine Hoffnung, die radikal ist und provoziert: die Idee der Allversöhnung. Eine Vorstellung von einem Gott, der größer liebt, als wir oft zu glauben wagen. Wenn Gott zu groß wird, um ihn zu fassen Martin erzählt, wie ihm – mitten im Zweifel – plötzlich die Größe Gottes aufgeht. Eine Größe, die sich nicht in Dogmen pressen lässt. Er verliert die alten Glaubenssätze – und mit ihnen auch den festen Boden. Doch in dieser Leere begegnet er einer neuen Form von Spiritualität: staunend, ehrlich, still. Was, wenn Gott nicht ergriffen, sondern nur geatmet werden kann? Gemeinschaft, Zweifel und die Kraft des Menschlichen Getragen wird Martin in dieser Phase von Menschen – Freund:innen, Weggefährt:innen, Mit-Zweifler:innen. Er erlebt: Manchmal ist genau dort Gott zu finden, wo man ihn nicht mehr erwartet. Nicht in theologischen Erklärungen, sondern in Nähe, Menschlichkeit und dem geteilten Fragen. Und vielleicht war das immer schon der tiefere Sinn von Glaube. Ein neuer Anfang – jenseits alter Sicherheiten „Vielleicht musst du sogar Gott verlieren, um ihn wirklich zu finden“, sagt Martin heute. Der Glaube, wie er ihn jetzt lebt, ist kein fester Standpunkt mehr, sondern ein Weg. Ein Prozess, der Raum lässt für Weite, Ehrlichkeit und Vertrauen – jenseits der Angst vor der Hölle, jenseits alter Gottesbilder. Eine Einladung, Glauben neu zu denken. Und neu zu hoffen. Mehr zu Martin ThomsWenn du dich in das Thema Allversöhnung vertiefen willst, kannst du hier Martins Buch erwerben: Es ist vollbracht!« Oder doch nicht? Seine Webpage und Online Studientage: www.martinthoms.de Instagram: @martinthoms.de Die Schiffbruch CrewModeriert von Martin Dreyer und Mirko Sander, zwei Schlüsselfiguren in der Geschichte der Jesus Freaks Bewegung seit den frühen 90ern. Diese beiden langjährigen Weggefährten, die ihre Freundschaft bei den Jesus Freaks Hamburg begannen, bringen jede Menge tiefe Einblicke und bewegende Geschichten in jede Folge unseres Podcasts. Für weitere Infos, Social Media und die Möglichkeit, uns zu unterstützen, besuche unseren Linktree: https://linktr.ee/schiffbruch.mit.jesus

Pluto startet am 20.08.2025 seinen Rücklauf in Tor 60 (Linie 6 – „Festigkeit/Limitierung“) und bleibt dort bis zum 05.12.2025. In dieser Phase rückt das Thema Grenzen, Regeln und Struktur ins Zentrum: Wo geben dir klare Rahmen Halt – und wo werden sie so starr, dass sie dich ausbremsen? Ich zeige dir im Video, warum rückläufiger Pluto eher „nach innen“ wirkt, wie sich Tor 60.6 zwischen kluger Disziplin und dogmischer Härte bewegt und woran du erkennst, ob du dich gerade an sinnvollen Begrenzungen orientierst oder an alten Prinzipien festhältst, die dich klein halten.Termin buchen.

Die in KI-Kreisen und auch sonstwo fast heilige Zahl 42 ist erreicht: Die AI Talk Hosts Jakob Steinschaden (Trending Topics, newsrooms) und Clemens Wasner (enliteAI, AI Austria) wühlen sich in dieser Folge durch diese Themen:Google FTC-Urteil überraschend mild: Strafe fällt viel harmloser aus als erwartet - Google darf weiterhin 20+ Milliarden für iPhone-Standard-Suchmaschine zahlen, muss aber Konkurrenten auch Optionen einräumen. Suchindex-Daten müssen an Mitbewerber weitergegeben werden.OpenAI braucht 80 Milliarden zusätzlich: Massiver Kapitalbedarf bis 2030 wegen eigener Halbleiter-Infrastruktur mit Broadcom. Gleichzeitig Expansion in Consumer-Bereiche wie Jobbörse - erinnert an Facebook's experimentelle Phase 2010-2014.Anthropic zahlt 1,5 Milliarden Buchvergleich: Etwa 3.000 Dollar pro Buch für illegale Nutzung in KI-Training. Gericht prüft noch Zulassung. Diskussion ob strategischer Zug gegen neue Konkurrenten oder Vorbereitung auf Apple-Übernahme.Mistral erhält 1,7 Milliarden Euro: Überraschend von Halbleiter-Ausrüster ASML (1,3 Mrd.) plus US-Investoren. Ungewöhnliche Partnerschaft weit entfernter Wertschöpfungsketten, vermutlich politisch motiviert für EU-Regulatoren.Bewertungsunterschiede extrem: Anthropic 183 Milliarden vs. Mistral 11-12 Milliarden Dollar - Faktoren zwischen US- und EU-KI-Champions zeigen Marktdominanz.Tool der Woche - JUA Wettermodelle: Schweizer KI-Labor entwickelt Energiemarkt-optimierte Wetterprognosen (IPT 1.5/2) für algorithmischen Stromhandel.Startup der Woche - 506.ai: Oberösterreichisches Unternehmen erforscht mit FH OÖ erfolgreich KI-Chatbot-Beeinflussung durch Textwerbung - Featured in Financial Times.

Back in the studio after Dragon Con Fun. Let's catch up on some news and feedback and see how Ashley feels about the Marvel Zombies Trailer. Patreon ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.patreon.com/mcucast⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Join The Stranded Panda Community! ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.strandedpanda.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Facebook Group: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/groups/spchat Learn more about your ad choices. Visit podcastchoices.com/adchoices

Laurence emphasizes the breakdown on offense, defense and special teams in the Bears 27-24 loss to the Vikings Monday night.

Dr. Tony Ebel addresses one of the most common challenges facing families with chronically ill children: healing interventions overload. Many parents are managing multiple therapies, dozens of supplements, and restrictive diets while feeling like nothing works and their child remains stuck or regresses.Dr. Tony reveals the counterintuitive truth that the most advanced healing approach is "less is more." He explains how well-intentioned interventions can overwhelm a child's already stressed nervous system. The solution is a three-phase approach: Phase 1 focuses exclusively on foundational Neurologically-Focused Chiropractic Care, Phase 2 gradually reintroduces therapies, and Phase 3 is where breakthrough healing occurs. The key message: healing comes from proper sequencing and the child's innate ability, not from piling on more interventions.Key Topics & Timestamps([00:00:00]) - The Overload Crisis - How millions of parents are overwhelmed managing multiple interventions without seeing results([00:04:00]) - When Good Interventions Go Bad - Why overwhelmed nervous systems cause children to plateau or regress despite "doing everything right"([00:09:00]) - Less Is More Philosophy - The advanced approach prioritizes foundation and sequencing over doing everything at once([00:11:00]) - The Computer & Circuit Breaker Analogies - Relatable explanations of how nervous system overload works([00:15:00]) - The Energy Theft Hierarchy - Scientific breakdown of how stress systematically affects gut, immune, and motor systems([00:21:00]) - The Three-Phase Action Plan - Foundation first (Phase 1), gradual reintroduction (Phase 2), breakthrough healing (Phase 3)([00:28:00]) - The Patience Factor & Next Steps - Honest discussion about the difficulty of slowing down and practical guidance for getting started-- Follow us on Socials: Instagram: @pxdocs Facebook: Dr. Tony Ebel & The PX Docs Network Youtube: The PX Docs For more information, visit PXDocs.com to read informative articles about the power of Neurologically-Focused Chiropractic Care. Find a PX Doc Office near me: PX DOCS DirectoryTo watch Dr. Tony's 30 min Perfect Storm Webinar: Click HereSubscribe, share, and stay tuned for more incredible episodes unpacking the power of Nervous System focused care for children!

Interview with Roshan Pujari, Founder & CEO, Stardust PowerRecording date: 8th September 2025Stardust Power is developing what could become one of America's largest lithium refineries, targeting a massive supply chain gap that represents both national security vulnerability and generational investment opportunity. The Oklahoma-based facility aims to produce 50,000 metric tons of battery-grade lithium carbonate annually when the entire United States currently produces only 20,000 tons.Founded by seasoned entrepreneur Roshan Pujari, who previously established boutique investment firm Vikasa Capital, Stardust identified processing as the critical bottleneck in lithium supply chains. "We really saw that the critical gap in the supply chain for lithium is processing capacity and that's when we founded Stardust Power to address that particular need," Pujari explained.The company's strategic advantage lies in its aggregation model, sourcing feedstock from Argentina, America's Smackover formation, and Canadian lithium fields. This approach aligns with broader industry trends as oil giants Exxon and Chevron enter lithium production. "We also see the economic model moving more towards the oil and gas market where you have local production with central refining," Pujari noted.Stardust has achieved critical development milestones that separate it from typical early-stage projects. The company secured major construction permits through a zero liquid discharge system and completed its FEL-3 engineering study with premier firm Primero USA. "We are already permitted to start major construction," Pujari stated.The project's financial structure leverages proven technology to enable 75-80% debt financing, potentially reducing the $500 million Phase 1 construction to just $100-125 million in equity requirements. Oklahoma has analyzed up to $257 million in state incentives, while major trading houses have expressed interest in purchasing 80-100% of production capacity.With minimal domestic competition and explosive demand growth, Stardust Power represents a rare opportunity to capture processing monopoly returns in America's critical mineral independence strategy.Sign up for Crux Investor: https://cruxinvestor.com

It wasn't a phase, mom will go over the life and crimes of teens and young adults.In part two of our look into the William Heirens case, we pick up where we left off after a string of brutal crimes rocked Chicago. This episode dives into the confessions, the trial, and the controversies that surrounded the case — raising questions that still linger decades later. Was justice truly served, or was William Heirens a convenient scapegoat?Follow us on all social media!Facebook - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/bucketmurd⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Twitter - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://twitter.com/TheMurderBucket⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/murdbucket/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok -⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@murderbucketpod⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://murderbucketpod.wordpress.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

JCO fellow Dr. Ece Cali speaks with JCO Associate Editor Dr. Thomas E. Stinchcombe to discuss the JCO article "Phase 2 Dose-Randomized Study of Sunvozertinib in Platinum-Pretreated Non-Small-Cell Lung Cancer with Epidermal Growth Factor Receptor Exon 20 Insertion Mutations (WU-KONG1B)", that was simultaneously released at the IASLC 2025 World Conference on Lung Cancer. TRANSCRIPT Dr. Ece Cali: Hello, and welcome to our series where we cover some of the top JCO papers published simultaneously with their abstract presentation at this year's most important oncology meetings. I am your host, Dr. Ece Cali, JCO editorial fellow, and I am joined by Dr. Tom Stinchcombe, JCO associate editor, to discuss the Journal of Clinical Oncology article and 2025 World Conference on Lung Cancer abstract presentation, “Phase II Dose-Randomized Study of Sunvozertinib in Platinum-Pretreated Non–Small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations.” The WU-KONG1B trial is a multinational, phase II study that investigated the efficacy and safety of different doses of sunvozertinib in patients with metastatic non-small cell lung cancer and EGFR exon 20 insertion mutations after progression on platinum based chemotherapy. Tom, before we dive into the results, could you walk us through the rationale for this study, and how does it fit into the current treatment options for patients with EGFR exon 20 insertion? Dr. Tom Stinchcombe: Thank you, Dr. Cali. I think the clinical context is always important. We have known that EGFR exon 20 insertions exist and that they are resistant to our currently available EGFR tyrosine kinase inhibitors, and I think there have been attempts in the past to develop a tyrosine kinase inhibitor, but there is a very narrow therapeutic window between the dose you need to inhibit the EGFR mutation in the cancer and the EGFR receptor on normal tissues, most notably the mucosa, the gut, and the skin. And so, our previous attempts have failed largely because the dose required was not tolerable for patients and they could not really stay on the drug for a long time or they were not very active. And so, I think there was a real desire to develop an EGFR tyrosine kinase inhibitor, and then, historically, the standard had been a platinum based doublet as the standard of care. And more recently, platinum based doublet with amivantamab has proven to be superior to platinum based chemotherapy alone. I think the context is also important that amivantamab is not necessarily available in all the countries, and so, there are patients who do not have access to amivantamab. Going to the rationale, I think that this drug had shown preliminary promise of having activity but without that being encumbered by those EGFR wild type toxicities, and, therefore, it was really explored in this larger study. Dr. Ece Cali: And what are some key findings from this trial? Dr. Tom Stinchcombe: So, I think that we should look at the study design. It is a little quirky, for lack of a better term, in that there is a randomization to 200 versus 300 mg, and then, there was a nonrandomized cohort of 300 mg. So, when you look at the study, if you are a purist, you will just look at the randomized patients. If you are sort of an aggregator, you look at all patients. So, it shows reporting on three cohorts, but I think the key findings are that the 200 mg and the 300 mg treatments had similar toxicities in terms of response rate, duration of response, and progression free survival. And as you know going through the review, there was a lot of queries from the reviewers as to which would be the preferred dose, and to me, I think this really illustrates a dose finding component to a trial design because there is a lot of debate about what the minimal effective dose is or the optimal dose. And in this case, having the two dose cohorts did provide us some valuable efficacy and toxicity information. And then, when I look at the study, I want to make sure it reflects my patient population, and about a quarter of patients had brain metastases, and about 15% had previous amivantamab, and about 5% to 10% had another EGFR tyrosine kinase inhibitor. Dr. Ece Cali: And what is the objective response rate and the duration of response? These are pretty good numbers for this patient population. Dr. Tom Stinchcombe: In the 200 mg cohort, it was about 46%. The duration of response was around 11 months, and the PFS was around 8 months. The 300 mg cohort was 46%, duration of response 9.8, and the median PFS is 6.9 months, and I think that this is greater activity than we have seen with our previous attempts at EGFR tyrosine kinase inhibitors. Dr. Ece Cali: And based on these data, FDA granted accelerated approval for sunvozertinib very recently at 200 mg once daily dosing in this setting. So, that is a major step forward for our patients. Dr. Stinchcombe, how does this impact your clinical practice, and what side effects should oncologists be watching for if they prescribe this medication? Dr. Tom Stinchcombe: So, I think it was very interesting that they chose the 200 mg dose, which I think was more tolerable, and when we kind of look at this, there still was a rate of diarrhea, all grade, rash, paronychia, which are the EGFR related toxicities. There can be some decreased appetite, stomatitis, and then, it can lead to some lab abnormalities, like increased CPK and creatinine that physicians have to be aware of. You know, how it will affect my practice is that all these patients had received a platinum based chemotherapy as the first line therapy. I think that this would become my preferred second line therapy for patients outside the context of a trial because of the activity and the tolerability. Dr. Ece Cali: And lastly, several other tyrosine kinase inhibitors are being evaluated for EGFR exon 20 insertion, including in the frontline setting. So, what are some of the outstanding questions in this space, and what data should our listeners keep an eye on moving forward? Dr. Tom Stinchcombe: I think you are right that now, there is going to be another EGFR tyrosine kinase that may become available in the next year, and there is another drug, furmonertinib, that is being investigated. I think, for the clinical question, is, well, can we move these into the first line setting? And actually, the development path has two ways of doing this. There is EGFR tyrosine kinase compared to platinum based chemotherapy, and then, platinum based chemotherapy with an EGFR tyrosine kinase versus platinum based chemotherapy, and both have their merits and strengths. And so, I think it is going to be very interesting as we see if those first line trials, one, can they be demonstrated to be superior to platinum based chemotherapy, and then by what magnitude and what the side effects are. But I think we are hoping that in the next couple of years, we will have an additional first line option for our patients. Dr. Ece Cali: Yeah, it is always great to have more options for our patients. Thank you, Dr. Stinchcombe, for speaking about the JCO article, “Phase II Dose-Randomized Study of Sunvozertinib in Platinum-Pretreated Non-Small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations.” Join us again for the latest JCO simultaneous publications. Please take a moment to rate, review, and subscribe to all ASCO podcast shows at asco.org/podcasts. Until then, enjoy the rest of World Lung Conference. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.  

Live Recorded Set from VirtualDJ Radio Hypnotica

Brad Rourke, CEO of Scottie Resources (TSX.V:SCOT – OTCQB:SCTSF), joins me to review a number of key ongoing initiatives and newsflow including the best ever drill hole assay returned to kick off the largest ever drill program, further derisking work building towards an upcoming Preliminary Economic Assessment (PEA), a bulk sample in progress, and an ore sorting study underway at the Scottie Gold Mine Project; located in the Golden Triangle of British Columbia.   We start off reviewing the initial high-grade drill results returned from the ongoing planned 25,000-30,000 meters exploration program at the Blueberry Contact Zone.   Highlights: Blueberry Contact drillhole SR24-364 intersected 30.1 grams per tonne (g/t) gold over 23.65 metres (m), including 83.3 g/t gold over 4.4 m at the Fifi vein. Blueberry Contact drillhole SR24-362 intersected 9.18 g/t gold over 21.00 m and 5.19 g/t gold over 6.00 m at the Blueberry vein zone. Blueberry Contact drillhole SR24-360 intersected 23.1 g/t gold over 2.00 m at the Fifi vein zone. 3 of the 5 reported holes have discreet intercepts of greater than 5 g/t gold in the siltstone host rock, including 29.8 g/t gold over 1.05 m in SR25-364.   Brad highlights that 4 diamond drill rigs have been turned across the property at the high-priority Blueberry Contact Zone, around the past-producing Scottie Gold Mine, including at the Wolf Zone discovered last season, and at the C & D veins. Brad points out that about 14,000 meters has been drilled thus far, and that a big percentage of the will be focused on upgrading the resources from inferred to indicated categories as well as targeting resource growth at the Blueberry Contact Zone, with a focus on the open pit and upper portions of the underground resources at both Blueberry and Scottie, and detailed testing of the siltstone side of the contact zone. We also review follow-up step-out drilling on the Wolf Zone target discovered in 2024 at the Scottie Gold Mine area.   Ongoing geotechnical and hydrogeology drilling will also provide data to inform mine design and assist efforts with the recent initiation of Baseline Environmental Studies. With all this exploration and fieldwork now underway, the Company remains on track to deliver a low-capex PEA based on a Direct Shipment Ore (DSO) scenario in October.  Brad reiterates that the management team and board believes this coming economics study will clearly highlight the significant, untapped value of the Scottie Gold Mine Project.  The company then plans to springboard over the Pre-Feasibility Study and head straight into work streams for a Feasibility Study (FS) with actual cost estimates and more detailed economics as the next major economic study to be undertaken.   Next we touched on the ongoing 10,000-tonne surface bulk sampling program where they have been blasting and mucking mineralized material from the road-accessable outcropping Bend Vein located on the north end of the Scottie Gold Mine Project.  This will be a nice opportunity to learn more about a number of metrics and provide a nice proof of concept, as well as generating some non-dilutive capital for the Company in the process.   When reviewing their direct-ship ore strategy, Brad highlighted that Scottie has one of the closest gold projects to a deep-sea shipping terminal, which based on its location is positioned in one of North America's cheapest commercial shipping lanes to Asia. In addition to the ease of a proposed open-pit mine, which already has an existing mine permit, there is also key external infrastructure in place, such as power lines and hauling roads right to site.  Ocean Partners recently participated in a financing for the company this summer, and has expressed interest in the offtake of this material in a development scenario.   Wrapping up we discussed the ongoing Phase 2 ore-sorting study underway, that will be a more advanced Feasibility Study level test of upgrading the ore, with the strategy to reduce the amount of waste rock before shipping.  Ore sorting could significantly enhance the efficiencies of the overall DSO strategy, and those results are due out in Q4.     If you have any questions for Brad regarding Scottie Resources, then please email them in to me at  Shad@kereport.com.   In full disclosure, Shad is a shareholder of Scottie Resources at the time of this recording and may choose to buy or sell shares at any time.   Click here to follow the latest news from Scottie Resources

Overwhelmed by conflicting business advice? Cut through the noise with Chris Cooper's proven system for building wealth as a gym owner. In this episode of “Run a Profitable Gym,” Chris explains how to move beyond the passion-first mentality that keeps most fitness entrepreneurs stuck and broke.He breaks down his four-phase roadmap for gym-owner wealth: Founder, Farmer, Tinker and Chief. These phases show you what to focus on right now, what to ignore and how to move toward financial freedom.Coop also shares candid stories from his early years of gym ownership, including mopping floors personally and trapping his business in Founder Phase. Everything changed when he focused on fixing the foundation first, stopped trying to market a broken gym, and started doing the right things as a CEO and business owner.Now as the CEO of Two-Brain Business, Cooper has helped thousands of fellow gym owners fix their businesses, too. He's minted more than 60 millionaire gym owners, and hundreds more are earning over $100,000 per year.It's time to break free from day-to-day operations and start building wealth. Tune in to get the full blueprint.LinksGym Owners UnitedBook a Call1:28 - Why gym owners get stuck7:44 - Founder Phase10:51 - Farmer Phase14:34 - Tinker Phase19:36 - Chief Phase

Phase 1: The Garden of Eden ( Gen 1:26; 2:17 ) God's policies were minimal and simple: ( 1 ) have children, ( 2 ) rule the world, and ( 3 ) don't eat from the tree of the knowledge of good and evil. Phase 2: The Old World ( Gen 4:26; 5:22 ) People invoked the name of God. Enoch walked with God, but over time, wickedness and violence spread like a plague resulting in the great reset of Noah's flood. Phase 3: The New World ( Gen 9:1-11; 11:6-9 ) God initiated three changes in policy: ( 1 ) humans could now eat meat, ( 2 ) no more global floods, and ( 3 ) capital punishment for murderers. Sadly, humanity rebelled with the result that God confused the languages. Phase 4: Covenant with Abraham ( Gen 12:1-3 ) After Abraham trusted God, God committed to him and his descendants to be their God, bless them, and give them a land. Phase 5: Covenant with Israel ( Exod 20:1-17 ) After rescuing Israel from Egypt, God gave Moses laws to write down. In the 40th year, God provided updates and new laws ( Exod 21:2 vs. Deut 15:12-14, 17 ). Phase 6: New Covenant ( Luke 22:19-20; Jer 31:31-32; Psalm 110:4; Heb 8:13; 7:11- 12, 22; Gal 3:23-26 ) Jesus brought new instruction. His death ratified a new covenant, that opened up a new relationship on the basis of faith not ancestry. Phase 7: The Kingdom of God ( Dan 7; Rev 21-22 ) When Christ returns, he will resurrect the faithful, establish God's kingdom on earth, and usher in an age of enduring peace, justice, and loveThe post Progressive Revelation first appeared on Living Hope.

The Change Leader's Roadmap process has nine phases. This episode presents the critical Upstream work of Phase I: Prepare to Lead the Change. It outlines the six Activities of this Phase and reviews the work of the Tasks for each Activity. While the lengthiest Phase, it sets up the project for success and demonstrates the importance of the leaders engaging in the foundational work to do so.Hosted by Ausha. See ausha.co/privacy-policy for more information.

① US President Donald Trump says the White House is ready to move to the second phase of sanctions against Russia. How realistic is it for the US to impose secondary tariffs on countries trading with Russia? (00:55)② Japan is now facing a month-long process to select its next prime minister following Shigeru Ishiba's resignation as leader of the ruling Liberal Democratic Party. Is the LDP facing the worst crisis since its founding? (12:38)③ Why has China's foreign trade in the first 8 months shown resilience? (24:19)④ We explore why the US trade deficit widened more than expected in July. (33:40)⑤ China has criticized Canadian and Australian warships transiting the Taiwan Strait as a provocation. Could Western warships' actions trigger a military clash? (45:22)

Phase fr33l33

In this sermon concluding the "It's Just a Phase" series, we'll explore the universal need for assurance and meaning in life. Everyone wants to know their life counts, no matter what generation they're a part of. We'll see in the story of Nicodemus in John 3:1-9 that true assurance comes not from worldly success but from the transformative love and grace of Jesus Christ. Being born again by faith gives our lives purpose and we can find our assurance in the grace of God. We'll remember to cherish life's small moments and focus on what truly matters: finding meaning and assurance at the Cross.

Welcome to HCPLive's 5 Stories in Under 5—your quick, must-know recap of the top 5 healthcare stories from the past week, all in under 5 minutes. Stay informed, stay ahead, and let's dive into the latest updates impacting clinicians and healthcare providers like you! Interested in a more traditional, text rundown? Check out the HCPFive! Top 5 Healthcare Headlines for August 31-September 5, 2025: 1. Mitapivat PDUFA for Thalassemia Delayed to December  The FDA extended the review timeline for mitapivat in thalassemia, with a new decision date set for December 2025. 2. Arcutis Submits sNDA for Roflumilast Cream 0.3% for Psoriasis in Children Aged 2-5 Years Arcutis submitted an sNDA seeking to expand roflumilast cream's indication to include plaque psoriasis in children as young as 2. 3. Zilebesiran, RNAi for Hypertension, Heads to Phase 3 Cardiovascular Outcomes Trial Alnylam is advancing zilebesiran into a phase 3 outcomes trial to evaluate its impact on cardiovascular risk in patients with uncontrolled hypertension. 4. RestorAATion-2: WVE-006 Achieves Durable Serum AAT Protein Production in AATD Wave Life Sciences reported durable serum AAT protein production with WVE-006 in AATD, supporting its potential for disease modification. 5. Phase 3 Data Show Amlitelimab Effective in Adults, Adolescents with Atopic Dermatitis Sanofi announced phase 3 results showing amlitelimab improved disease severity and skin clearance in moderate-to-severe atopic dermatitis.

In this episode of Communicable, Angela Huttner and Erin McCreary invite two titans of vaccinology, Barney Graham (Atlanta, USA), former deputy director of the NIH NIAID Vaccine Research Center and architect of the mRNA vaccines against COVID-19, and Gary Kobinger (Galveston, USA), leading virologist in the development of the first effective Ebola vaccine, rVSV-ZEBOV, for a candid conversation about their direct experience building two of the most well known vaccines to date, and deploying them to the public. The episode also reviews the different vaccine platforms and addresses vaccine hesitancy, equitable access to vaccines, and global health equity. This episode was edited by Kathryn Hostettler and peer reviewed by Eren Ozturk of Ankara University, Ankara, Türkiye.  Terms and sourcesVSV, vesicular stomatitis virusZEBOV, Zaire Ebolavirus rVSV-ZEBOV, recombinant vesicular stomatitis virus expressing the (Zaire) Ebolavirus glycoprotein (vaccine)VRC, the NIH Vaccine Research Center of NIAID Morehouse School of Medicine Satcher Global Health Equity InstituteGuardRX, https://www.guardrx.org/en/who-we-are/ ReferencesMarzi A, et al. VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain. Science 2015. DOI: 10.1126/science.aab3920 Agnandji S, Huttner A, Zinser M, et al. Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe. New Engl J Med 2015. DOI: 10.1056/NEJMoa1502924Graham BS and Corbett KS. Prototype pathogen approach for pandemic preparedness: world on fire. J Clin Invest 2020. DOI: 10.1172/JCI139601Jackson LA, Anderson EJ, Rouphael NG, et al. An mRNA Vaccine against SARS-CoV-2 - Preliminary Report. New Engl J Med 2020. DOI: 10.1056/NEJMoa2022483

A version of this essay was published by firstpost.com at https://www.firstpost.com/opinion/what-fuels-anti-india-hate-in-the-west-13932053.htmlI am personally very pro-America, yet I too have been baffled by the noises emanating from the Trump administration regarding India, particularly from one aide. Peter Navarro, apparently some trade muckity-muck, has had a field day accusing India of various sins. Apart from the entertainment value, this leads to a serious question: Why? And why now?There is reason to believe, by connecting the dots, that there is indeed a method behind this madness. It is not a pure random walk: there is a plan, and there are good reasons why the vicious attack on India has been launched at this time and in this manner. Of course, this is based on open source and circumstantial evidence: I have no inside information whatsoever.In this context, consider what is arguably the greatest political thriller of all time: "Z" (1969) by Costa-Gavras. It is based on a real-life political murder in Greece, where a popular left-leaning candidate for President was covertly assassinated by the ruling military junta.The way the plot unravels is when the investigating magistrate, masterfully played by Jean-Louis Trintignant, notices a curious phenomenon: the use of a single phrase "lithe and fierce like a tiger", used verbatim by several eye-witnesses. He realizes that there was a criminal conspiracy to get rid of the inconvenient candidate, with plausible deniability. Words and phrases have subtle meanings, and they reveal a great deal.Thus, let me bring to your notice the following tweets:* “India could end the Ukraine war tomorrow: Modi needs to pick a side” (August 5)* “Europeans love to whinge about Trump and to claim he is soft on Russia. But after 3 years it is Donald J Trump who has finally made India pay a price for enabling Putin's butchery.” (August 6)* Speaker: “[the American taxpayer] gotta fund Modi's war”. TV Anchor (confused): “You mean Putin's war?”. Speaker: “No, I mean Modi's war”. (August 28)Do you, gentle reader, notice a pattern?Now let me tell you who the authors of these posts are. The first quoted an article by an officer in the British Special Forces, which means their covert, cloak-and-dagger military people.The second was by Boris Johnson, former British Prime Minister. Johnson, incidentally, has been accused of single-handedly spiking ceasefire talks between Russia and Ukraine in 2022, when there was a possibility that the whole sorry spectacle of the war could have been settled/brought to a close.The third is by the aforementioned Peter Navarro on an American TV channel, Bloomberg Television.I don't know about you, but it seems to me that these three statements are lineal descendants of each other, one leading seamlessly to the next.This is how narratives are built, one brick in the wall after another. In reality, India has not contravened any sanctions in buying oil from Russia, and in fact has helped maintain a cap on oil prices, which were rising because of the Ukraine-Russia war. But then who needs truth if narrative will suffice?My hypothesis is that the anti-India narrative – as seen above – has been created by the British Deep State, otherwise known as Whitehall. First from the spooks, then from the former Prime Minister, and then virally transmitted to the American Deep State. It is my general belief that the British are behind much mischief (sort of the last gasp of Empire) and have been leading the Americans by the nose, master-blaster style.Britain has never tasted defeat at the hands of Russia; while France (Napoleon) and Germany (Hitler) have. Plus the US Military Industrial Complex makes a lot of money from war.A malignant British meme, intended to hurt Russia, is now turned on to India, which is, for all intents and purposes, an innocent bystander. Britain has had a thing about both Russia (“The Great Game”) and now India, and it was precisely why it created ‘imperial fortress' Pakistan, with which to trouble, and if possible, hurt both.Then there was the second set of tweets that took things one step further. Navarro, all warmed up, blamed “Brahmins” for “profiteering by buying Russian oil at the cost of the Indian people” in a broadcast on September 1. Why he would be bothered about the “Indian people” is a good question. But what was far more interesting, indeed hilarious, was the near-simultaneous, and absurdly wrong, set of tweets by a whole group of INDI Alliance mavens.They ‘explained', in almost identical words, that what Navarro meant was not “Brahmins”, but “Boston Brahmins”, a term coined in 1860 by Oliver Wendell Holmes, a doctor/essayist, to refer to traditional US East Coast elites, generally WASPs (White Anglo Saxon Protestants) who dominate the corridors of power in the US. Many claim to be descended from the original Pilgrims, Puritan extremists from Britain, who arrived in Plymouth on the Mayflower in 1620.They go to private (‘prep') schools like Philips Exeter Academy, then Harvard or Yale, then Goldman Sachs, then Harvard Business School, and generally end up running the country as a hereditary, endogamous caste. It is very difficult for outsiders to marry into or enter this circle, although money helps. For example the Irish Catholic Kennedy clan is part of this caste because they made big bucks (partly by smuggling liquor during the Prohibition era), even though the Irish are generally looked down upon.I have long claimed that America is full of castes like this, which include the investment-banker caste, the lawyer caste, the doctor caste: all go to the same schools, the same colleges, marry each other, etc. In fact they do form the kind of exclusionary group that the western narrative imputes to India jati-varna. Anyway that's a long story, and that's not the point: it is the tweets by, for example, Karti Chidambaram, Sagarika Ghose, Saket Gokhale, et al.They were so ‘spontaneous', so near-identical, and so outright idiotic that it is impossible that they came from anything other than a ‘toolkit' supplied by the usual suspects: the regime-change specialists. And their claim was not even accurate: Navarro was indeed targeting Hindus and Brahmins, as is evident from the following tweet. There is no earthly reason for him to choose this image of Modi, other than that he was coached into doing so.So we go back to the original question: why? Who hates Hindus so much?There are a number of other incidents where Indians (in particular Hindus) have been targeted in various countries: Ireland recently; Australia some time ago and again now, see below an anti-immigration (particularly anti-Indian) rally on August 31st; Canada with its Khalistanis running amok (lest we forget, 40 years ago, they downed Air India Kanishka).Let us note the curious coincidence that these are all countries where the British have influence: Canada and Australia are in effect their vassals. Ireland is not, and I suspect the British are hated there, but somehow in the last few weeks, this British prejudice has spilled over with “Irish teenagers” physically attacking Indians (including women and children). I wonder if the “Irish teenagers” are really British agents provocateurs.So let's put two and two together: who hates Indians, Hindus and Brahmins? Why, Pakistanis, of course. And they have been burned a little by Operation Sindoor. Pahalgam didn't quite turn out the way they thought it would, considering it was scheduled during the India visit of J D Vance accompanied by his Indian/Hindu-origin wife, Usha Chilukuri Vance. That might explain why there's a sudden explosion of social-media hatred by ISI and CCP bots against Indians.Pahalgam was Phase 2 of the regime-change operation. By so visibly targeting and murdering Hindus in Pahalgam, the Pakistanis calculated they could induce massive rioting by Hindus against Muslims, which would be an excuse for “the rules-based liberal international order” to step in, exile Modi, and um… restore order, as in Bangladesh. The usual playbook.Alas, “the best laid schemes o' mice an' men gang aft agley”, and Pakistan got a whipping instead, and some of their (US or China-supplied?) nuclear assets apparently went up in smoke. But make no mistake, the regime-change gang will redouble its efforts.Phase 1 had been the 2024 elections where there were surprising losses by the BJP. Phase 3 is the ‘vote-chori' wailing by the INDI Alliance: odd, considering nobody knows which passport(s) Rahul Gandhi holds. Phase 4 is the ongoing ‘Project 37' in which renegade BJP MPs are supposed to bring down the central government.Pakistan, and its various arms, including the Khalistan project, participate with great enthusiasm in these various phases. And for all intents and purposes, the UK has now become a Pakistani colony. Recursive master-blaster, as I conjectured: Pakistani-Britons control Whitehall, Whitehall controls the US Deep State. Here's Britain's new Home Secretary, Shabana Mahmood, in the words of a suddenly-awake Briton on September 6th.An Emirati strategist, Amjad Taha, asked a valid question: why is there more terrorism in the UK than in the Middle East?Wait, there's more. Here's a loudmouth Austrian who wants to dismantle India, long a Pakistani dream. And the map is by some Jafri, which sounds like a Pakistani surname. The Austrian also wants Rahul Gandhi to be the next Prime Minister.Pakistan is itself unraveling, as can be seen in Balochistan which is in open rebellion. Their Khalistani dream is new, but Kerala and the Northeast as Islamist entities were standard memes even from Chaudhury Rehmat Ali who dreamt up Pakistan in the first place in the 1930s.Pakistan just got a boost, however, with OSINT identifying a US C-17 (a giant military cargo plane) arriving to resupply Nur Khan Airbase. This raises the question again: were US personnel and assets decimated there by Indian missiles during Operation Sindoor? Is that why the US got so upset? Did Trump read the riot act to Modi, which led to the ‘ceasefire'? Now did they replenish the F-16s etc that were blown up? See, no Pakistani losses!I imagine this goes well with the newly announced “US Department of War”. I only hope the war target here is China, not India.Speaking of US internal politics, it was utterly laughable to see Jake Sullivan, President Biden's NSA, coming to the defense of India in Foreign Affairs. He directly engineered the vicious regime change in Bangladesh, but now he's full of solicitous concern! Nice little U-turn!From a global perspective, I believe that both China and the US are intent on knee-capping India. That is the logical response from an incumbent power when there is a rising insurgent power: the Thucydides Trap idea. It is a back-handed compliment to India that it is in splendid isolation, and has to pretend to rush into the arms of China because of Trump's withering assault.India will survive the hate; but Indian-Americans may find themselves in some jeopardy as the MAGA types are now focusing their ire on them.It is, as I said, the Abhimanyu Syndrome: India is completely alone (the RIC lovefest is just marketing). That is the bad news, and also the good news. If everyone (the US Deep State, Whitehall, CCP, ISI, Soros) is against India, it means India matters. Someone said India is the ultimate swing state. No: India is the incipient superpower, the only one that can make it a G3 rather than a G2. Naturally, the G2 is not very happy to let one more into their cozy club.1910 words, 7 Sept 2025 This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit rajeevsrinivasan.substack.com/subscribe

Heute Abend ist der Vollmond der Superstar: Mit Einbruch der Dunkelheit zeigt er sich komplett verfinstert am Osthimmel. Die totale Phase endet um 20.53 Uhr - danach wandert der Mond langsam aus dem Erdschatten heraus. Lorenzen, Dirk www.deutschlandfunk.de, Sternzeit

Indianapolis Rowing Center was like lots of other clubs, running several small Learn to Row sessions each year but struggling with retention. Then IRC rower, coach, and brand new Board member Lisa Stickley proposed something big. Really big. She wanted to develop a new type of introduction to rowing program that would get 120 registrants in the boathouse door and on the water all within the month of July. With the support of the Board and club membership, IRC's First Strokes program moved from big idea, to social media marketing campaign, to eight sessions a week for four weeks, plus three big social events. As of today, the retention rate is 40%. Find out from Lisa how she made it happen and how your club can think outside the box to truly use LTR to grow membership and create community connections. . QUICK LOOK 0:00 - Intro 05:05 - Lisa's Rowing Week was an 11! 06:57 - The Huddle 08:37 - Hot Seat Q&A 11:23 - Rowing origin story 15:05 - Transition into competitive rowing, the rower life cycle, and Lisa's “iron sharpens iron” motto 20:43 - About Indianapolis Rowing Center 23:25 - The idea that became IRC's First Strokes program 25:39 - Big goal: register 120 new rowers 30:28 - Coaches, volunteers, and operational logistic strategy 39:10 - Phase 2: retention and integration of new rowers into club programs  42:48 - Club culture shifts 47:52 - Considerations for future growth of First Strokes 49:25 - Keys to success: fun and friends 53:31 - Steady State Network news and notes . To see photos of Lisa, IRC's huge First Strokes program, and to get links to the people and events mentioned in this episode, check out the show notes on our website. . This episode was made possible in part by Breakwater Realty, RowSource, and our Supporters. . Steady State Podcast is hosted and edited by Rachel Freedman and Tara Morgan. Tara provides additional audio engineering, books show guests, and is our sponsor and donor coordinator. Rachel writes our scripts and e-newsletter, and manages the website and social media. Our theme music is by Jonas Hipper. . SHOP SSN GEAR: www.steadystatenetwork.com/shop SIGN UP FOR THE SSN NEWSLETTER: www.steadystatenetwork.com/newsletter MAKE A DIFFERENCE: www.steadystatenetwork.com/support  Check out more Steady State Network here:  FB - /SteadyStateNetwork IG - @SteadyStateNetwork BLUESKY - steadystatenetwork.bsky.social FB - /AllieswithOars IG - @AllieswithOars Connect on FB and IG with the hosts: Rachel Freedman - @RowSource Tara Morgan - @CmonBarber  

To celebrate the first 7 years of my business (a Saturn cycle), I am looking back at the habits, healing, and challenges I faced in the various chapters along my path.  In this particular installment, I look at a period marked by a lot of Death, where learning to hold grief, and to trust myself as I faced uncertain futures, became essential to how I hold everything in life, including the art of my career.   This will likely be the most personal and vulnerable chapter in this whole series. It was a year of rollicking change, grounding in ritual, and surrendering to trust.  I call the frameworks that emerged at this time Vulture Magic and The Emergent No. These grew mostly from my personal life, especially 4th, 7th, and 8th house relationships and experiences.   To catch the previous chapters of this story, tune into Episodes 179, 183, and 190. To explore the history of the ideas I built out this year: Emergent No & Vulture Magic, Dumbo's Feather, and Coincidence as a Practice with Matt Bull.  Mentioned: Danica Boyce and Sam Garcia.  +++ Alert: There's a HUGE ECLIPSE SALE AT MY SCHOOL from September 5-8! Get new and old favorites for 50-75% off their original prices. The price is already applied to the courses included in the sale.  Save $200 on all 5 of the de-commissioned courses when you bundle them.  Everyone who spends over $1k across the sale will receive the full set of my Living the Signs workbooks for free. That's a $297 value.  +++ E M E R G E N C E  A S T R O L O G Y ⁠⁠https://brittenlarue.com/ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram: ⁠⁠⁠⁠⁠@brittenlarue Order Living Astrology Join my newsletter here Check out my new podcast CRYSTAL BALLERS on Spotify, Podbean, and Apple. +++ Podcast art: Angela George. Podcast music: Jonathan Koe.

[อะไรยังไง] สรุป Timeline The Conjuring Phase 1

This episode is for the writer who wants to make sure that the reader will be on her side and know what she's thinking and what she's experiencing. Writing yourself as a character can be tricky, because you can assume the reader either needs explanations that are actually too much information or that the reader can read your mind. Today we're going to learn how to see yourself as a character and how to know when to trust your reader and when they need a little hand holding. Let's get started.Enroll in The Memoir Method today, (Phase 1 is available instant access!).You can find me on Instagram @charlottejanewrites, Facebook, and YouTube.Join my email list to stay up to date on the podcast and everything else going on in Charlotte Writes.

Phase one is complete. Phase two begins. And it's all about delivery. But just how hard is it for governments to do the delivery bit of governing? The IfG podcast team give their expert view.   Civil servants are key to making a success of the government's policies and priorities - perhaps none more so than the high flying fast stream. But who are they - and is this cohort doing a good job? A new IfG report reveals all.   Plus: Reform Party conference preview – we speak to former Reform head of press Gawain Towler.   Catherine Haddon presents. With Hannah Keenan, Rebecca McKee and Teodor Grama Learn more about your ad choices. Visit podcastchoices.com/adchoices

Hour 1 of Jake & Ben on September 5, 2025 How good is this Utah team? Is it a Ferrari? Top 3 Stories of the Day: What a crazy start to the NFL Season, Phase 1 of Delta Center Renovation is nearly complete, Other CFB Games to look out for tomorrow.  Clippers Owner Steve Ballmer defends himself, says he got scammed. 

Top 3 Stories of the Day: What a crazy start to the NFL Season, Phase 1 of Delta Center Renovation is nearly complete, Other CFB Games to look out for tomorrow. 

⚠️ The Collapse Chronicles – Episode: World War 3

Show notes at pharmacyjoe.com/episode1058. In this episode, I’ll discuss recent guidelines about fluid removal in critically ill patients. The post 1058: ESICM guideline on fluid therapy in adult critically ill patients: Part 3--fluid removal at de-escalation phase appeared first on Pharmacy Joe.

You are listening to Voices of Your Village, and today's episode is such a grounding one. I got to sit down with my dear friend, Eli Harwood, who you may know as @attachmentnerd over on Instagram, to dive into a topic that comes up so often, school refusal. If you've ever had a kid clinging to the doorframe or break down in tears before drop off, or you've wondered when to push and when to pause, this one's for you. Eli brings her therapist lens and lived experience to this conversation with so much empathy and wisdom and humor. We talk about what's really going on beneath school refusal, how to meet our kids with connection and structure, and why scaffolding their nervous system matters more than forcing compliance. This episode is full of practical strategies and those aha moments that help us show up differently for our kids and ourselves. Y'all, we are so close to Big Kids, Bigger Feelings- my next book publishing. I'm so jazzed for it to get into your hands. We have a couple pre-order bonuses, so if you head over right now to seedandsew.org/book before September 16th, and order that bad boy and pop your order number in, we will send you some bonuses. Alright folks, let's dive in. Connect with Eli: Instagram: @attachmentnerd Website: https://attachmentnerd.com/ Order the book: Raising Securely Attached Kids: Using Connection-Focused Parenting to Create Confidence, Empathy, and Resilience Podcast: https://attachmentnerd.com/podcast Connect with us: Instagram: @seed.and.sew  TikTok: @seedandsew Seed and Sew's NEW Regulation Questionnaire: Take the Quiz Pre-order Big Kids, Bigger Feelings now!  Order Tiny Humans, Big Emotions  Website: seedandsew.org Music by: Ruby Adams and  Bensound Learn more about your ad choices. Visit podcastchoices.com/adchoices

Have you ever looked at your work-in-progress and thought it was absolutely hideous? According to acclaimed sculptor Arlene Shechet, that's exactly where the magic happens.In this eye-opening exploration of artistic process, we dive deep into Shechet,'s philosophy of creation, where listening to your work becomes just as important as making it. The American sculptor, whose gravity-defying arrangements have earned places in the Metropolitan Museum of Art and the Whitney, reveals how embracing the "ugly" phases of creation leads to unexpected beauty."I have to have a real appetite for ugly," Shechet, confesses about her creative process. "There are so many points where this thing is just hideous and yet I have to believe in it." This sentiment resonates profoundly with our own artistic journeys—recognizing that every meaningful piece goes through an awkward adolescence before reaching maturity.What truly sets Shechet, apart is her approach to artistic control. After carefully crafting her ceramic sculptures, she surrenders them to a 2,000-degree kiln where "all bets are off." This balance between meticulous creation and acceptance of unpredictability forms the heart of her practice. She meticulously documents every experiment in notebooks, creating a scientific approach to artistic discovery that allows her work to continually evolve.We're particularly struck by Shechet,'s description of her studio as "both a farm and a factory"—a place that cultivates growth while producing tangible objects. Her commitment to pushing boundaries by creating open systems rather than settling into comfortable patterns mirrors our own philosophy of artistic development. When she declares, "I want to make something more than an idea," she articulates the ultimate challenge facing every serious artist: creating work that resists easy description and demands deeper engagement.Join us in this fascinating conversation about embracing discomfort, fighting against creative stagnation, and finding joy in the uncertain journey of making art that matters. Whether you're a seasoned creator or just beginning your artistic path, Shechet,'s wisdom offers valuable perspective on sustaining growth through perpetual discovery.Please visit:https://art21.org/watch/art-in-the-twenty-first-century/s7/arlene-shechet-in-secrets-segment/https://www.youtube.com/watch?v=Dh_lDHY0ZO4https://www.frieze.com/video/arlene-shechet-and-sheena-wagstaff-frieze-masters-podcastSend us a message - we would love to hear from you!Make sure to follow us on Instagram here:@justmakeartpodcast @tynathanclark @nathanterborg

Anthony explains the differences between this transfer of ownership and the others we've seen recently, but also discusses why it might not matter. Jeanie Buss is operating as governor for now and will for the foreseeable future, but Mark Walter also has every reason to make sure she does so in a way he's comfortable with. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

He is accused of masterminding an attempt to stay in power after losing his bid for re-election in 2022, which culminated in his supporters breaking into and vandalising government buildings in the capital, Brasília. Bolsonaro has always denied any wrongdoing and said the charges were politically motivated. His cause has been adopted by US President Donald Trump, who has called the trial a "witch-hunt" using it as justification for imposing 50% tariffs on some Brazilian goods and sanctioning the Supreme Court judge leading the proceedings. Also on the programme: will a new boss at one of fashion's biggest magazines bring the glory days back? And we hear about the mysterious disappearance of the Lebanese cleric, Musa al-Sadr in Libya, back in 1978.(Picture: An inflatable figure depicting Brazil's former President Jair Bolsonaro stands near protesters outside party headquarters.Credit:REUTERS/Amanda Perobelli)